Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)

Affiliations

• ¹ Institute of Cardiovascular and Medical Sciences (M.M.Y.L., K.A.G., K.J.M.B., G.R., C.B., R.T.C., L.C., K.F.D., N.N.L., K.M., C.J.P., J.R.P., P.W., A.W., A.R., J.J.V.M., P.S.J., M.C.P., N.S., P.B.M.), University of Glasgow, UK.
• ² Queen Elizabeth University Hospital, Glasgow, UK (M.M.Y.L., K.A.G., G.R., C.B., R.T.C., K.F.D., N.N.L., K.M., J.T., R.W., A.W., J.J.V.M., P.S.J., P.B.M.).
• ³ Glasgow Royal Infirmary, UK (M.M.Y.L., G.R., J.R.P., M.C.P., N.S.).
• ⁴ Department of Clinical Physics and Bioengineering, NHS Greater Glasgow and Clyde, UK (S.A.-S., P.H.B.).
• ⁵ Robertson Centre for Biostatistics (K.W., A.M.), University of Glasgow, UK.
• ⁶ University of Leeds, UK (B.A., S.S.).
• ⁷ University Hospital Crosshouse, Kilmarnock, UK (V.C.).
• ⁸ Golden Jubilee National Hospital, Glasgow, UK (J.G.D., M.C.P.).
• ⁹ Siemens Healthcare GmbH, Erlangen, Germany (B.K.).
• ¹⁰ Forth Valley Royal Hospital, Larbert, UK (C.L.).
• ¹¹ University Hospital Ayr, UK (V.L.).
• ¹² Aberdeen Royal Infirmary, UK (V.L.).
• ¹³ Royal Alexandra Hospital, Paisley, UK (C.L.M.).
• ¹⁴ University Hospital Monklands, Airdrie, UK (C.J.P.).
• ¹⁵ University of Sheffield, UK (K.S., S.S.).
• ¹⁶ West Glasgow Ambulatory Care Hospital, UK (I.A.S.).